home / stock / syn / syn news

SYN News and Press, Synthetic Biologics Inc. From 08/01/19

Stock Information
Company Name: Synthetic Biologics Inc.
Stock Symbol: SYN
Market: NYSE
Website: syntheticbiologics.com
Menu
SYN SYN Quote SYN Short SYN News SYN Articles SYN Message Board
Get SYN Alerts

News, Short Squeeze, Breakout and More Instantly...
SYN - Synthetic Biologics to Report 2019 Second Quarter Operational Highlights and Financial Results on August 8, 2019

ROCKVILLE, Md. , Aug. 1, 2019 /PRNewswire/ --  Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that the Company intends to release its op...
SYN - Synthetic Biologics Regains Compliance with NYSE American Continued Listing Standards

ROCKVILLE, Md. , July 1, 2019 /PRNewswire/ --  Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today receipt, on June 28, 2019 , of notificati...

SYN - Synthetic Biologics Regains Compliance with NYSE American Continued Listing Standards

ROCKVILLE, Md. , July 1, 2019 /PRNewswire/ --  Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today receipt, on June 28, 2019 , of notificati...

SYN - Synthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2019 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (SYN) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Vincent Perrone – Director-Corporate Communication Steven Shallcross – Chief Executive and Financial Officer Conference Call Participants Presentation ...
SYN - Synthetic Biologics reports Q1 results

Synthetic Biologics (NYSEMKT: SYN ): Q1 GAAP EPS of -$0.25. More news on: Synthetic Biologics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SYN - Synthetic Biologics Reports First Quarter 2019 Operational Highlights and Financial Results

ROCKVILLE, Md. , May 8, 2019 /PRNewswire/ --  Synthetic Biologics, Inc.  (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided an operational update and reported...

SYN - Synthetic Biologics to Report 2019 First Quarter Operational Highlights and Financial Results on May 8, 2019

ROCKVILLE, Md. , April 30, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that the Company intends to release its opera...
SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q4 2018 Results - Earnings Call Transcript

Synthetic Biologics Inc. (SYN) Q4 2018 Earnings Conference Call February 27, 2019 16:30 ET Company Participants Vincent Perrone - Director, Corporate Communications Steven Shallcross - CEO & CFO Vince Wacher - Head, Product & Corporate Development Conference Call Parti...

SYN - Synthetic Biologics reports FY results

Synthetic Biologics (NYSEMKT: SYN ): FY GAAP EPS of -$4.06. More news on: Synthetic Biologics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

SYN - Synthetic Biologics Reports 2018 Year End Operational Highlights and Financial Results

ROCKVILLE, Md. , Feb. 27, 2019 /PRNewswire/ -- Synthetic Biologics, Inc.  (NYSE American: SYN), a clinical-stage company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided a clinical programs update and report...
Previous 10 Next 10